FY2025 · ended Dec 31, 2025 · Revenue $648,231, +1002.0% YoY · Filed May 6, 2026
Polomar Health Services, Inc. (PMHS) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $648,231 and a net loss of $10.7 million. As of Jun 30, 2026 it held $178,872 in cash and investments and $14,864 in total debt.
Revenue (TTM)
$3.17M
Net income (TTM)
$-9.46M
-361.1% vs year-ago TTM
Operating cash flow (TTM)
$-6,956
+99.2% vs year-ago TTM
Free cash flow
$-1.11M
EPS
$-0.39
-680.0% vs prior year
Dividend per share
None
Shares outstanding
28.05M
+5.2% vs prior year
Net cash
$164,008
as of Jun 30, 2026
Operating margin
-295.0%
FY 2026
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMHS (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Palm Harbor, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1265521
- Former names
- Trustfeed Corp. (until Oct 11, 2024); HEALTHMED SERVICES LTD (until Apr 5, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2022 |
|---|---|---|---|
| Revenue | $648,231 | $58,824 | $34,526 |
| Operating income | -$10.6M | -$1.3M | — |
| Net income | -$10.7M | -$1.3M | — |
| Diluted EPS | -$0.39 | -$0.05 | — |
| Operating cash flow | -$395,995 | -$1.0M | — |
| Free cash flow | — | -$1.1M | — |
| Total assets | $390,043 | $10.0M | — |
| Total liabilities | $1.6M | $1.4M | — |
| Stockholders' equity | -$1.2M | $8.6M | — |
| Cash and investments | $132,150 | $6,191 | — |
| Total debt | $14,864 | $49,181 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Restatement
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 19, 2026 | Oct 19, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change, Bylaw or fiscal year change
|
Jul 30, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 20, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 17, 2026 | Jul 17, 2026 |
All 150 Polomar Health Services, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.